J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Cipro (TN)

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 10 USDMF, 6 CEP/COS, 7 JDMF, 3 EU WC, 4 KDMF, 2 NDC API, 26 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

46 Drugs in Development

46 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

681 FDF Dossiers, 60 FDA Orange Book, 343 Europe, 3 Canada, 22 Australia, 88 South Africa, 165 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML), SUSPENSION/DROPS;OTIC - 0.3%;0.1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 5 SPI Pharma, 7 DKSH, 6 Faran Shimi Pharmaceutical, 10 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 35 BASF, 1 BioSpectra, 1 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 2 Esteem Industries, 2 Finar, 14 Gangwal Chemicals, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 32 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

82 Fillers, Diluents & Binders, 55 Coating Systems & Additives, 40 Disintegrants & Superdisintegrants, 34 Thickeners and Stabilizers, 33 Controlled & Modified Release, 32 Granulation, 32 Solubilizers, 31 Direct Compression, 25 Parenteral, 23 Topical, 21 Lubricants & Glidants, 19 Film Formers & Plasticizers, 19 Co-Processed Excipients, 16 Taste Masking, 10 Chewable & Orodispersible Aids, 9 Emulsifying Agents, 7 API Stability Enhancers, 7 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

DIGITAL CONTENT

58 News #PharmaBuzz

58 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 336 Regulatory FDF Prices, 2 Annual Reports

MARKET PLACE

72 APIs, 38 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 8 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 10 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/06/2025	Bayer AG	Germany	Bayer Korea Ltd.	20110516-85-D-92-17	Ciprofloxacin	2011-05-16	Bayer AG	Germany	Friedrich-Ebert-Str. 217-333, 42117 Wuppertal, Germany
28/06/2025	Ildong Pharmaceutical	South Korea	Ildong Pharmaceutical Co., Ltd.	20110131-85-D-97-14	Ciprofloxacin	2011-01-31	@Shaoxing Jingxin Pharmaceutical Co., Ltd.	South Korea	53, Gongdan-ro 98beon-gil, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do @No.31 , Weisan Road, Hangzhou Bay Shangyu Economic and Technological Development Area, Shangyu, 312369, Zhejiang Province, PRChina

Cipro (TN)

Cipro (TN)

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

42 API Suppliers

10 USDMF

6 CEP/COS

7 JDMF

3 EU WC

4 KDMF

2 NDC API

26 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

46 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

681 FDF Dossiers

60 FDA Orange Book

343 Europe

3 Canada

22 Australia

88 South Africa

165 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML)

SUSPENSION/DROPS;OTIC - 0.3%;0.1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Rochem International Inc

5 SPI Pharma

7 DKSH

6 Faran Shimi Pharmaceutical

10 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 ACG Worldwide

12 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

35 BASF

1 BioSpectra

1 Clariant

11 Corel Pharma Chem

6 DFE Pharma

2 Esteem Industries

2 Finar

14 Gangwal Chemicals

5 Ideal Cures

4 Ingredion Pharma Solutions

32 Kerry

4 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

2 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

30 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

11 Sigachi Industries

4 Silverline Chemicals

3 The Dow Chemical Company

3 Ulanqab Kema New Material

INJECTABLE;INJECTION - 200MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 400MG/200ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons